AMRX logo

Amneal Pharmaceuticals (AMRX) Revenue

Annual revenue:

$2.79B+$400.35M(+16.73%)
December 31, 2024

Summary

  • As of today (June 21, 2025), AMRX annual revenue is $2.79 billion, with the most recent change of +$400.35 million (+16.73%) on December 31, 2024.
  • During the last 3 years, AMRX annual revenue has risen by +$700.29 million (+33.45%).
  • AMRX annual revenue is now at all-time high.

Performance

AMRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

Quarterly revenue:

$695.42M-$35.10M(-4.80%)
March 31, 2025

Summary

  • As of today (June 21, 2025), AMRX quarterly revenue is $695.42 million, with the most recent change of -$35.10 million (-4.80%) on March 31, 2025.
  • Over the past year, AMRX quarterly revenue has increased by +$36.23 million (+5.50%).
  • AMRX quarterly revenue is now -4.80% below its all-time high of $730.52 million, reached on December 31, 2024.

Performance

AMRX Quarterly revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

TTM revenue:

$2.83B+$36.23M(+1.30%)
March 31, 2025

Summary

  • As of today (June 21, 2025), AMRX TTM revenue is $2.83 billion, with the most recent change of +$36.23 million (+1.30%) on March 31, 2025.
  • Over the past year, AMRX TTM revenue has increased by +$334.93 million (+13.42%).
  • AMRX TTM revenue is now at all-time high.

Performance

AMRX TTM revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMRXincome statement metrics

AMRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.7%+5.5%+13.4%
3 y3 years+33.5%+39.8%+34.9%
5 y5 years+71.8%+39.5%+68.6%

AMRX Revenue Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+33.5%-4.8%+39.8%at high+34.9%
5 y5-yearat high+71.8%-4.8%+49.7%at high+68.6%
alltimeall timeat high+174.4%-4.8%+173.0%at high+989.1%

AMRX Revenue History

DateAnnualQuarterlyTTM
Mar 2025
-
$695.42M(-4.8%)
$2.83B(+1.3%)
Dec 2024
$2.79B(+16.7%)
$730.52M(+4.0%)
$2.79B(+4.2%)
Sep 2024
-
$702.47M(+0.1%)
$2.68B(+3.2%)
Jun 2024
-
$701.78M(+6.5%)
$2.60B(+4.1%)
Mar 2024
-
$659.19M(+6.8%)
$2.50B(+4.2%)
Dec 2023
$2.39B(+8.2%)
$616.98M(-0.5%)
$2.39B(+0.3%)
Sep 2023
-
$620.04M(+3.5%)
$2.39B(+3.2%)
Jun 2023
-
$599.05M(+7.4%)
$2.31B(+1.7%)
Mar 2023
-
$557.54M(-8.6%)
$2.27B(+2.7%)
Dec 2022
$2.21B(+5.7%)
$609.76M(+11.8%)
$2.21B(+3.4%)
Sep 2022
-
$545.56M(-2.5%)
$2.14B(+0.8%)
Jun 2022
-
$559.36M(+12.4%)
$2.12B(+1.2%)
Mar 2022
-
$497.63M(-7.3%)
$2.10B(+0.2%)
Dec 2021
$2.09B
$536.90M(+1.6%)
$2.09B(+1.3%)
Sep 2021
-
$528.59M(-1.2%)
$2.07B(+0.5%)
Jun 2021
-
$535.08M(+8.5%)
$2.06B(+3.5%)
DateAnnualQuarterlyTTM
Mar 2021
-
$493.11M(-3.3%)
$1.99B(-0.3%)
Dec 2020
$1.99B(+22.5%)
$510.03M(-1.8%)
$1.99B(+6.0%)
Sep 2020
-
$519.29M(+11.8%)
$1.88B(+8.1%)
Jun 2020
-
$464.66M(-6.8%)
$1.74B(+3.6%)
Mar 2020
-
$498.53M(+25.5%)
$1.68B(+3.2%)
Dec 2019
$1.63B(-2.2%)
$397.33M(+5.0%)
$1.63B(-5.8%)
Sep 2019
-
$378.28M(-6.5%)
$1.73B(-5.4%)
Jun 2019
-
$404.64M(-9.3%)
$1.82B(-0.5%)
Mar 2019
-
$446.12M(-10.3%)
$1.83B(+10.3%)
Dec 2018
$1.66B(+60.9%)
$497.53M(+4.4%)
$1.66B(+14.0%)
Sep 2018
-
$476.49M(+15.2%)
$1.46B(+17.9%)
Jun 2018
-
$413.79M(+50.4%)
$1.24B(+14.2%)
Mar 2018
-
$275.19M(-6.2%)
$1.08B(+34.1%)
Dec 2017
$1.03B(+1.5%)
$293.37M(+15.2%)
$807.97M(+57.0%)
Sep 2017
-
$254.73M(-2.0%)
$514.60M(+98.0%)
Jun 2017
-
$259.87M
$259.87M
Dec 2016
$1.02B
-
-

FAQ

  • What is Amneal Pharmaceuticals annual revenue?
  • What is the all time high annual revenue for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals annual revenue year-on-year change?
  • What is Amneal Pharmaceuticals quarterly revenue?
  • What is the all time high quarterly revenue for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals quarterly revenue year-on-year change?
  • What is Amneal Pharmaceuticals TTM revenue?
  • What is the all time high TTM revenue for Amneal Pharmaceuticals?
  • What is Amneal Pharmaceuticals TTM revenue year-on-year change?

What is Amneal Pharmaceuticals annual revenue?

The current annual revenue of AMRX is $2.79B

What is the all time high annual revenue for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high annual revenue is $2.79B

What is Amneal Pharmaceuticals annual revenue year-on-year change?

Over the past year, AMRX annual revenue has changed by +$400.35M (+16.73%)

What is Amneal Pharmaceuticals quarterly revenue?

The current quarterly revenue of AMRX is $695.42M

What is the all time high quarterly revenue for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high quarterly revenue is $730.52M

What is Amneal Pharmaceuticals quarterly revenue year-on-year change?

Over the past year, AMRX quarterly revenue has changed by +$36.23M (+5.50%)

What is Amneal Pharmaceuticals TTM revenue?

The current TTM revenue of AMRX is $2.83B

What is the all time high TTM revenue for Amneal Pharmaceuticals?

Amneal Pharmaceuticals all-time high TTM revenue is $2.83B

What is Amneal Pharmaceuticals TTM revenue year-on-year change?

Over the past year, AMRX TTM revenue has changed by +$334.93M (+13.42%)
On this page